Beam Therapeutics is transitioning from a scientific platform to a late-stage genetic medicine company with a clear commercial bridge. BEAM's $1.2B cash position supports a runway into mid-2029, ...
SAN ANTONIO — If the Minnesota Twins do move Royce Lewis to second base, his agent seems open to the possibility. Though he isn’t privy to the team’s plans, agent Scott Boras compared the Twins’ young ...
The New York Mets' 2026 season has been a major disappointment, with several players failing to meet expectations. One bright spot, however, has been first baseman Jared Young when he has been healthy ...
As they look for ways to upgrade their roster and return to the postseason in 2025, improving the infield defense is a must for the Boston Red Sox this offseason. As a team, they were sixth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results